banner
Together we Drive the Future
2017-06-272018-03-092018-02-13

Stem Cell Summit 2018
Date: April 12 - 13, 2018
Venue: Boston, MA, USA


Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean



Dear Colleague,

GTCbio is proud to present the Stem Cell Summit 2018, to be held in Boston, MA. The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.

 
The 15th Stem Cell Summit includes two conferences including the joint plenary session:

 
Joint Sessions:

  1. Plenary Keynote: Historical Perspective and State of the Industry
  2. Round Table Sessions
  3. Ready, Set, Grow – New Company/Technology Pitch Competition
  4. Award Ceremony and Closing Keynote Session – Predictions for the Future

Stem Cell Research & Regenerative Medicine:

  1. Advances in Adult Stem Cell Research
  2. Advances in Pluripotent Stem Cell Research
  3. Translation to the Clinic: What’s in the Pipeline
  4. Revolution in Immunotherapy

Stem Cell Product Development & Commercialization:

  1. Stem Cells for Drug Discovery and Disease Modeling
  2. Partnering between Industry, Academia and CROs to Advance Research
  3. Manufacturing and Scalable Processes for Cell Therapy
  4. Regulatory and Funding Challenges

We hope to see you in Boston!

Best regards,

The 2018 Advisory Committee

2018 Advisory Board Members
Anthony Ting, Athersys
Robert Deans, BlueRock Therapeutics
Douglas Losordo, Caladrius Biosciences
Evan Y. Snyder, Sanford-Burnham Medical Research Institute
Mark Zimmerman, Viacyte
Matthew Durdy, Cell Therapy Catapult
Gil Sambrano, California Institute for Regenerative Medicine
Alain Vertès, NxR Biotechnologies GmbH
Khalid Shah, Harvard Medical School
Satish Medicetty, GTCbio